S&P TSX Capped Composite...

US Dollar vs CAD

Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.

Get Started

TARA Protara Therapeutics Inc

1.69

0.00 (0.00%)

Pre Market

Last Updated: 03:16:39

Delayed by 15 minutes

Other Filing

This regulatory filing also includes additional resources:
filename1.pdf

Protara Therapeutics (NASDAQ:TARA)
Historical Stock Chart
From Sep 2024 to Oct 2024

Click Here for more Protara Therapeutics Charts.

Protara Therapeutics (NASDAQ:TARA)
Historical Stock Chart
From Oct 2023 to Oct 2024

Click Here for more Protara Therapeutics Charts.

Artara Therapeutics, Inc. News

Form 4 - Statement of changes in beneficial ownership of securities
Thursday 12 September 2024 (4 weeks ago) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Tuesday 10 September 2024 (4 weeks ago) • Edgar (US Regulatory)

Protara Therapeutics Announces Completion of First Cohort in Phase 2 STARBORN-1 Trial of TARA-002 in Pediatric Patients with Lymphatic Malformations
Monday 9 September 2024 (1 month ago) • GlobeNewswire Inc.

Protara Therapeutics Announces Results from THRIVE-1, a Prospective Observational Study Evaluating the Prevalence of Choline Deficiency and Liver Injury in Patients Dependent on Parenteral Support
Monday 9 September 2024 (1 month ago) • GlobeNewswire Inc.

Protara Therapeutics to Present at the H.C. Wainwright 26th Annual Global Investment Conference
Tuesday 3 September 2024 (1 month ago) • GlobeNewswire Inc.

Form 4 - Statement of changes in beneficial ownership of securities
Friday 30 August 2024 (1 month ago) • Edgar (US Regulatory)

Form S-8 - Securities to be offered to employees in employee benefit plans
Tuesday 6 August 2024 (2 months ago) • Edgar (US Regulatory)

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Tuesday 6 August 2024 (2 months ago) • Edgar (US Regulatory)

Form 8-K - Current report
Tuesday 6 August 2024 (2 months ago) • Edgar (US Regulatory)

Protara Therapeutics Announces Second Quarter 2024 Financial Results and Provides a Business Update
Tuesday 6 August 2024 (2 months ago) • GlobeNewswire Inc.

Form 4 - Statement of changes in beneficial ownership of securities
Thursday 18 July 2024 (3 months ago) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Thursday 11 July 2024 (3 months ago) • Edgar (US Regulatory)

More Artara Therapeutics, Inc. News Articles

Accredited Solutions (PK)

Halozyme Therapeutics

RespireRx Pharmaceuticals (CE)

Asia Broadband (PK)

Bounce Mobile Systems (PK)

TPT Global Tech (PK)

GNCC Capital (CE)

Intergrated Cannabis Sol... (PK)

Enzolytics (PK)

Laser Photonics

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions